Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid β-peptide presentation to Th1 cells

Journal of Immunology

Volumn 171, Issue 5, 2003, Pages 2216-2224

  Monsonego, Alon ^a,b   Imitola, Jaime ^a   Zota, Victor ^a   Oida, Takatoku ^a   Weiner, Howard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; IMMUNOMODULATION; MICROGLIA; MOUSE; NEUROTOXICITY; NONHUMAN; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0041428141     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.5.2216     Document Type: Article

References (54)

1. Streilein, J. W., S. Okamoto, Y. Sano, and A. W. Taylor. 2000. Neural control of ocular immune privilege. Ann. NY Acad. Sci. 917:297.
2. Moalem, G., A. Monsonego, Y. Shani, I. R. Cohen, and M. Schwartz. 1999. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 13:1207.
3. Aloisi, F., E. Ambrosini, S. Columba-Cabezas, R. Magliozzi, and B. Serafini. 2001. Intracerebral regulation of immune responses. Ann. Med. 33:510.
4. Hickey, W. F., B. L. Hsu, and H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:254.
5. Wekerle, H. 1993. T-cell autoimmunity in the central nervous system. Intervirology 35:95.
6. Wekerle, H., M. Bradl, C. Linington, G. Kaab, and K. Kojima. 1996. The shaping of the brain-specific T lymphocyte repertoire in the thymus. Immunol. Rev. 149:231.
7. Becher, B., A. Prat, and J. P. Antel. 2000. Brain-immune connection: immunoregulatory properties of CNS-resident cells. Glia 29:293.
8. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118.
9. Ford, A. L., E. Foulcher, F. A. Lemckert, and J. D. Sedgwick. 1996. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184:1737.
10. Pender, M. P., and M. J. Rist. 2001. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 36:137.
11. Hickey, W. F., and H. Kimura. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290.
12. Hickey, W. F., K. Vass, and H. Lassmann. 1992. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J. Neuropathol. Exp. Neurol. 51:246.
13. Williams, K., X. Alvarez, and A. A. Lackner. 2001. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36:156.
14. Fischer, H. G., U. Bonifas, and G. Reichmann. 2000. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J. Immunol. 164:4826.
15. Fischer, H. G., and G. Reichmann. 2001. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 166:2717.
16. Santambrogio, L., S. L. Belyanskaya, F. R. Fischer, B. Cipriani, C. F. Brosnan, P. Ricciardi-Castagnoli, L. J. Stern, J. L. Strominger, and R. Riese. 2001. Developmental plasticity of CNS microglia. Proc. Natl. Acad. Sci. USA 98:6295.
17. Re, F., S. L. Belyanskaya, R. J. Riese, B. Cipriani, F. R. Fischer, F. Granucci, P. Ricciardi-Castagnoli, C. Brosnan, L. J. Stern, J. L. Strominger, and L. Santambrogio. 2002. Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation. J. Immunol. 169:2264.
18. Zhang, Z., P. Nadeau, W. Song, D. Donoviel, M. Yuan, A. Bernstein, and B. A. Yankner. 2000. Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1. Nat. Cell Biol. 2:463.
19. Selkoe, D. J. 1999. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A2.
20. McGeer, E. G., and P. L. McGeer. 1998. The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33:371.
21. Bradt, B. M., W. P. Kolb, and N. R. Cooper. 1998. Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide. J. Exp. Med. 188:431.
22. Gonzalez-Scarano, F., and G. Baltuch. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22:219.
23. El Khoury, J., S. E. Hickman, C. A. Thomas, L. Cao, S. C. Silverstein, and J. D. Loike. 1996. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382:716.
24. Husemann, J., J. D. Loike, T. Kodama, and S. C. Silverstein. 2001. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar β-amyloid. J. Neuroimmunol. 114:142.
25. Smits, H. A., N. M. de Vos, J. W. Wat, T. van der Bruggen, J. Verhoef, and H. S. Nottet. 2001. Intracellular pathways involved in TNF-α and superoxide anion release by Aβ(1-42)-stimulated primary human macrophages. J. Neuroimmunol. 115:144.
26. Wyss-Coray, T., C. Lin, F. Yan, G. Q. Yu, M. Rohde, L. McConlogue, E. Masliah, and L. Mucke. 2001. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med. 7:612.
27. Schenk, D., R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, et al. 1999. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173.
28. Weiner, H. L., C. A. Lemere, R. Maron, E. T. Spooner, T. J. Grenfell, C. Mori, S. Issazadeh, W. W. Hancock, and D. J. Selkoe. 2000. Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol. 48:567.
29. Maron, R., W. W. Hancock, A. Slavin, M. Hattori, V. Kuchroo, and H. L. Weiner. 1999. Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines. Int. Immunol. 11:1573.
30. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
31. Karandikar, N. J., C. L. Vanderlugt, T. Eagar, L. Tan, J. A. Bluestone, and S. D. Miller. 1998. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161:192.
32. Schaub, M., S. Issazadeh, T. H. Stadlbauer, R. Peach, M. H. Sayegh, and S. J. Khoury. 1999. Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 96:158.
33. Akama, K. T., C. Albanese, R. G. Pestell, and L. J. Van Eldik. 1998. Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism. Proc. Natl. Acad. Sci. USA 95:5795.
34. Heneka, M. T., H. Wiesinger, L. Dumitrescu-Ozimek, P. Riederer, D. L. Feinstein, and T. Klockgether. 2001. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J. Neuropothol. Exp. Neurol. 60:906.
35. Haas, J., B. Storch-Hagenlocher, A. Biessmann, and B. Wildemann. 2002. Inducible nitric oxide synthase and argininosuccinate synthetase: co- induction in brain tissue of patients with Alzheimer's dementia and following stimulation with β-amyloid 1-42 in vitro. Neurosci. Lett. 322:121.
36. Badie, B., J. Schartner, J. Vorpahl, and K. Preston. 2000. Interferon-γ induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro. Exp. Neurol. 162:290.
37. van der Veen, R. C., T. A. Dietlin, L. Pen, J. D. Gray, and F. M. Hofman. 2000. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-γ is essential but insufficient. Cell. Immunol. 206:125.
38. van der Veen, R. C. 2001. Nitric oxide and T helper cell immunity. Int. Immunopharmacol. 1:1491.
39. Coleman, J. W. 2001. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 1:1397.
40. Mazzoni, A., V. Bronte, A. Visintin, J. H. Spitzer, E. Apolloni, P. Serafini, P. Zanovello, and D. M. Segal. 2002. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168:689.
41. Akiyama, H., S. Barger, S. Barnum, B. Bradt, J. Bauer, G. M. Cole, N. R. Cooper, P. Eikelenboom, M. Emmerling, B. L. Fiebich, et al. 2000. Inflammation and Alzheimer's disease. Neurobiol. Aging 21:383.
42. Cooper, N. R., R. N. Kalaria, P. L. McGeer, and J. Rogers. 2000. Key issues in Alzheimer's disease inflammation. Neurobiol. Aging 21:451.
43. Sahrbacher, U. C., F. Lechner, H. P. Eugster, K. Frei, H. Lassmann, and A. Fontana. 1998. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1332.
44. Fenyk-Melody, J. E., A. E. Garrison, S. R. Brunnert, J. R. Weidner, F. Shen, B. A. Shelton, and J. S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:2940.
45. O'Brien, N. C., B. Charlton, W. B. Cowden, and D. O. Willenborg. 2001. Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease. J. Immunol. 167:5904.
46. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907.
47. Aloisi, F. 2001. Immune function of microglia. Glia 36:165.
48. Phillips, L. M., and L. A. Lampson. 1999. Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs. hippocampus after-local injection of IFN-γ. J. Neuroimmunol. 96:218.
49. Aloisi, F., R. De Simone, S. Columba-Cabezas, G. Penna, and L. Adorini. 2000. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J. Immunol. 164:1705.
50. Tarkowski, E., A. Wallin, B. Regland, K. Blennow, and A. Tarkowski. 2001. Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol Scand 103:166.
51. Togo, T., H. Akiyama, E. Iseki, H. Kondo, K. Ikeda, M. Kato, T. Oda, K. Tsuchiya, and K. Kosaka. 2002. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124:83.
52. Spera, P. A., J. A. Ellison, G. Z. Feuerstein, and F. C. Barone. 1998. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251:189.
53. Flanders, K. C., R. F. Ren, and C. F. Lippa. 1998. Transforming growth factor-βs in neurodegenerative disease. Prog. Neurobiol. 54:71.
54. Weiner, H. L., and D. J. Selkoe. 2002. Inflammation and therapeutic vaccination in CNS diseases. Nature 420:879.